FDA Drug Application (202040) for ELETRIPTAN HYDROBROMIDE by TEVA PHARMS USA

Back to FDA Applications sponsored by TEVA PHARMS USA

Application Number202040
Product Number001
FormTABLET; ORAL
DosageEQ 20MG BASE
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameELETRIPTAN HYDROBROMIDE
Active IngredientELETRIPTAN HYDROBROMIDE

Active IngredientCount
List of drugs with Active Ingredient ELETRIPTAN HYDROBROMIDE2


Back to FDA Applications sponsored by TEVA PHARMS USA